Chronic food administration of Salvia sclarea oil reduces animals' anxious and dominant behavior

Journal of Medicinal Food

Volumn 16, Issue 3, 2013, Pages 216-222

  Gross, Moshe ^a   Nesher, Elimelech ^a   Tikhonov, Tatiana ^a   Raz, Olga ^a   Pinhasov, Albert ^a  

^a ARIEL UNIVERSITY   (Israel)

Author keywords

Anxiety; Corticosterone; Dominant Submissive Relationship; Omega 3; Sage; Salvia sclarea

Indexed keywords

ANXIOLYTIC AGENT; CORTICOSTERONE; OMEGA 3 FATTY ACID; PLANT EXTRACT; SALVIA SCLAREA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ELEVATED PLUS MAZE TEST; FEMALE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; SALVIA; SALVIA SCLAREA; THERAPY EFFECT; TRANQUILIZING ACTIVITY;

AFFECT; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CORTICOSTERONE; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; MICE; MICE, INBRED STRAINS; PHYTOTHERAPY; PLANT OILS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SALVIA;

EID: 84875196964     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0137     Document Type: Article

References (47)

1. Pešić PZ, Banković V: Investigation on the essential oil of cultivated Salvia sclarea L. Flavour Fragr J 2003;18: 228-230
2. Kara Y, Kocak A, Citil OB, Tulukcu E: A comparative study of the fatty acid composition and lipid content of Salvia sclarea. Chem Nat Compounds 2010;46: 612-614
3. Azcan N, Ertan A, Demirci B, Baser KHC: Fatty acid composition of seed oils of twelve Salvia species growing in Turkey. Chem Nat Compounds 2004;40: 218-221 (Pubitemid 39187878)
4. Goren AC, Kilic T, Dirmenci T, Bilsel G: Chemotaxonomic evaluation of Turkish species of Salvia: Fatty acid compositions of seed oils. Biochem Syst Ecol 2006;34: 160-164 (Pubitemid 43117217)
5. Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70: 560s-569s.
6. Riediger ND, Othman RA, Suh M, Moghadasian MH: A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009;109: 668-679
7. Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC; International Society for the Study of Fatty Acids and Lipids, ISSFAL: Alphalinolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009;80: 85-91
8. Simopoulos AP: The importance of the ratio of omega-6/ omega-3 essential fatty acids. Biomed Pharmacother 2002;56: 365-379 (Pubitemid 35232740)
9. Howe P, Buckley J: Dietary requirements for omega-6 and omega-3 PUFAs: Is the balance relevant? Ann Nutr Metab 2009;55(Suppl 1): 7
10. Soh NL, Walter G, Baur L, Collins C: Nutrition, mood and behaviour: A review. Acta Neuropsychiatr 2009;21: 214-227
11. Frangou S, Lewis M, McCrone P: Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. Br J Psychiatry 2006;188: 46
12. Lin PY, Su KP: A meta-analytic review of double-blind, placebocontrolled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007;68: 1056-1061
13. Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59: 913
14. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al.: Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Australas Psychiatry 2008;42: 192-198 (Pubitemid 351234188)
15. Su KP, Huang SY, Chiu CC, Shen WW: Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebocontrolled trial. Euro Neuropsychopharmacol 2003;13: 267-271 (Pubitemid 36904053)
16. Green P, Gispan-Herman I, Yadid G: Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression. J Lipid Res 2005;46: 1093-1096 (Pubitemid 43109824)
17. Green P, Anyakoha N, Yadid G, Gispan-Herman I, Nicolaou A: Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: Implications for pathophysiology. Prostaglandins Leukot Essent Fatty Acids 2009;80: 213-220
18. Bourre JM: Dietary omega-3 fatty acids for women. Biomed Pharmacother 2007;61: 105-112
19. Feder Y, Nesher E, Ogran A, et al.: Selective breeding for dominant and submissive behavior in Sabra mice. J Affect Disord 2010;126: 214-222
20. Malatynska E, Goldenberg R, Shuck L, et al.: Reduction of submissive behavior in rats: A test for antidepressant drug activity. Pharmacology 2002;64: 8-17 (Pubitemid 33151608)
21. Pinhasov A, Crooke J, Rosenthal D, Brenneman D, Malatynska E: Reduction of submissive behavior model for antidepressant drug activity testing: Study using a video-tracking system. Behav Pharmacol 2005;16: 657-664 (Pubitemid 41682201)
22. Nesher E, Peskov V, Rylova A, Raz O, Pinhasov A: Comparative analysis of the behavioral and biomolecular parameters of four mouse strains. J Mol Neurosci 2012;46: 276-284
23. Malatynska E, Knapp RJ: Dominant-submissive behavior as models of mania and depression. Neurosci Biobehav Rev 2005;29: 715-737 (Pubitemid 40755462)
24. Prut L, Belzung C: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur J Pharmacol 2003;463: 3-33 (Pubitemid 36205070)
25. Pellow S, Chopin P, File SE, Briley M: Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14: 149-167 (Pubitemid 16239568)
26. Innis SM: Omega-3 fatty acids and neural development to 2 years of age: Do we know enough for dietary recommendations? J Pediatr Gastroenterol Nutr 2009;48 Suppl 1: S16-S24
27. Venzala E, Garcia-Garcia AL, Elizalde N, Delagrange P, Tordera RM: Chronic social defeat stress model: Behavioral features, antidepressant action, and interaction with biological risk factors. Psychopharmacology (Berl) 2012;224: 313-325
28. Ulrich-Lai YM, Herman JP: Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009;10: 397-409
29. de Kloet ER, Joels M, Holsboer F: Stress and the brain: From adaptation to disease. Nat Rev Neurosci 2005;6: 463-475 (Pubitemid 40769171)
30. de Kloet ER: About stress hormones and resilience to psychopathology. J Neuroendocrinol 2008;20: 885-892 (Pubitemid 351858742)
31. Moussaieff A, Gross M, Nesher E, Tikhonov T, Yadid G, Pinhasov A: Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals. J Psychopharmacol 2012;26: 1584-1593
32. Malatynska E, Pinhasov A, Creighton CJ, et al.: Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships. Neurosci Biobehav Rev 2007;31: 904-919 (Pubitemid 47299257)
33. Alexopoulos GS, Morimoto SS: The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry 2011;26: 1109
34. Song C, Wang H: Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35: 760-768
35. Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M: In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35: 744-759
36. Dantzer R, O'Connor JC, Lawson MA, Kelley KW: Inflammation- associated depression: From serotonin to kynurenine. Psychoneuroendocrinology 2011;36: 426-436
37. Gardner A, Boles RG: Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2010
38. Eckert GP, Franke C, No?ldner M, et al.: Plant derived omega-3- fatty acids protect mitochondrial function in the brain. Pharmacol Res 2010;61: 234-241
39. Seol GH, Shim HS, Kim PJ, et al.: Antidepressant-like effect of Salvia sclarea is explained by modulation of dopamine activities in rats. J Ethnopharmacol 2010;130: 187-190
40. Nakamura A, Fujiwara S, Matsumoto I, Abe K: Stress repression in restrained rats by (R)-(-)-linalool inhalation and gene expression profiling of their whole blood cells. J Agric Food Chem 2009;57: 5480-5485
41. Nakamura A, Fujiwara S, Shijima T, et al.: Neuron differentiation- related genes are up-regulated in the hypothalamus of odorant-inhaling rats subjected to acute restraint stress. J Agric Food Chem 2010;58: 7922-7929
42. Dunkel Schetter C: Psychological science on pregnancy: Stress processes, biopsychosocial models, and emerging research issues. Annu Rev Psychol 2011;62: 531-558
43. Markham JA, Koenig JI: Prenatal stress: Role in psychotic and depressive diseases. Psychopharmacology (Berl) 2011;214: 89
44. Glover V: Annual Research Review: Prenatal stress and the origins of psychopathology: An evolutionary perspective. J Child Psychol Psychiatry 2011;52: 356-367
45. Laloux C, Mairesse J, Van Camp G, et al.: Anxiety-like behaviour and associated neurochemical and endocrinological alterations in male pups exposed to prenatal stress. Psychoneuroendocrinology 2012;37: 1646-1658
46. Abdul Aziz NH, Kendall DA, Pardon MC: Prenatal exposure to chronic mild stress increases corticosterone levels in the amniotic fluid and induces cognitive deficits in female offspring, improved by treatment with the antidepressant drug amitriptyline. Behav Brain Res 2012;231: 29-39
47. van den Hove DL, Jakob SB, Schraut KG, et al.: Differential effects of prenatal stress in 5-Htt deficient mice: Towards molecular mechanisms of gene · environment interactions. PLoS One 2011;6: E22715